UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 174

Sortiert nach

Caractéristiques microbiologiques et cliniques des patients hospitalisés pour suspicion d’infection à Middle East Respiratory Syndrome coronavirus (MERS-CoV) au cours de la période 2013–2016

Médecine et maladies infectieuses, 2017-06, Vol.47 (4), p.S122-S123

2017

Link zum Volltext

Verfügbarkeit prüfen

C-reactive protein levels in the early stage of COVID-19

Médecine et maladies infectieuses, 2020-06, Vol.50 (4), p.332-334

Wang, L.

2020

Link zum Volltext

Verfügbarkeit prüfen

Features of anosmia in COVID-19

Médecine et maladies infectieuses, 2020-08, Vol.50 (5), p.436-439

2020

Link zum Volltext

Verfügbarkeit prüfen

Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients

Médecine et maladies infectieuses, 2020-08, Vol.50 (5), p.397-400

2020

Link zum Volltext

Verfügbarkeit prüfen

Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study

Journal of substance abuse treatment, 2021-10, Vol.129, p.108374-108374, Article 108374

2021

Link zum Volltext

Verfügbarkeit prüfen

Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic

Journal of substance abuse treatment, 2021-05, Vol.124, p.108272-108272, Article 108272

2021

Link zum Volltext

Verfügbarkeit prüfen

Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19

Journal of substance abuse treatment, 2021-12, Vol.131, p.108449-108449, Article 108449

2021

Link zum Volltext

Verfügbarkeit prüfen

A clash of epidemics: Impact of the COVID-19 pandemic response on opioid overdose

Journal of substance abuse treatment, 2021-01, Vol.120, p.108158-108158, Article 108158

2021

Link zum Volltext

Verfügbarkeit prüfen

Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine

Journal of substance abuse treatment, 2020-11, Vol.118, p.108124-108124, Article 108124

2020

Link zum Volltext

Verfügbarkeit prüfen

Clinician perspectives on methadone service delivery and the use of telemedicine during the COVID-19 pandemic: A qualitative study

Journal of substance abuse treatment, 2021-05, Vol.124, p.108288-108288, Article 108288

2021

Link zum Volltext

Verfügbarkeit prüfen

COVID-19-related treatment service disruptions among people with single- and polysubstance use concerns

Journal of substance abuse treatment, 2021-02, Vol.121, p.108180-108180, Article 108180

2021

Link zum Volltext

Verfügbarkeit prüfen

Online digital recovery support services: An overview of the science and their potential to help individuals with substance use disorder during COVID-19 and beyond

Journal of substance abuse treatment, 2021-01, Vol.120, p.108152-108152, Article 108152

2021

Link zum Volltext

Verfügbarkeit prüfen

Perspectives of opioid use disorder treatment providers during COVID-19: Adapting to flexibilities and sustaining reforms

Journal of substance abuse treatment, 2022-01, Vol.132, p.108514-108514, Article 108514

2022

Link zum Volltext

Verfügbarkeit prüfen

Telehealth sustains patient engagement in OUD treatment during COVID-19

Journal of substance abuse treatment, 2021-03, Vol.122, p.108215-108215, Article 108215

2021

Link zum Volltext

Verfügbarkeit prüfen

Focus on Middle East respiratory syndrome coronavirus (MERS-CoV)

Médecine et maladies infectieuses, 2020-05, Vol.50 (3), p.243-251

2020

Link zum Volltext

Verfügbarkeit prüfen

Reimagining patient-centered care in opioid treatment programs: Lessons from the Bronx during COVID-19

Journal of substance abuse treatment, 2021-03, Vol.122, p.108219-108219, Article 108219

2021

Link zum Volltext

Verfügbarkeit prüfen

Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis

Journal of substance abuse treatment, 2022-10, Vol.141, p.108801-108801, Article 108801

2022

Link zum Volltext

Verfügbarkeit prüfen

Changes in methadone take-home dosing before and after COVID-19

Journal of substance abuse treatment, 2022-02, Vol.133, p.108552-108552, Article 108552

2022

Link zum Volltext

Verfügbarkeit prüfen

The impact of COVID-19 on substance use disorder treatment in California: Service providers' perspectives

Journal of substance abuse treatment, 2022-02, Vol.133, p.108544-108544, Article 108544

2022

Link zum Volltext

Verfügbarkeit prüfen

The provision of counseling to patients receiving medications for opioid use disorder: Telehealth innovations and challenges in the age of COVID-19

Journal of substance abuse treatment, 2021-01, Vol.120, p.108163-108163, Article 108163

2021

Link zum Volltext

Verfügbarkeit prüfen

Impacts of COVID-19 on residential treatment programs for substance use disorder

Journal of substance abuse treatment, 2021-04, Vol.123, p.108255-108255, Article 108255

2021

Link zum Volltext

Verfügbarkeit prüfen

Low-barrier buprenorphine during the COVID-19 pandemic: A rapid transition to on-demand telemedicine with wide-ranging effects

Journal of substance abuse treatment, 2021-12, Vol.131, p.108444-108444, Article 108444

2021

Link zum Volltext

Verfügbarkeit prüfen

Rapid transitional response to the COVID-19 pandemic by opioid agonist treatment programs in Ukraine

Journal of substance abuse treatment, 2021-02, Vol.121, p.108164-108164, Article 108164

2021

Link zum Volltext

Verfügbarkeit prüfen

Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade?

Journal of substance abuse treatment, 2021-03, Vol.122, p.108196-108196, Article 108196

2021

Link zum Volltext

Verfügbarkeit prüfen

Using telehealth to improve buprenorphine access during and after COVID-19: A rapid response initiative in Rhode Island

Journal of substance abuse treatment, 2021-05, Vol.124, p.108283-108283, Article 108283

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 174

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(174)

Publikationsform

Artikel
(168)
Berichte
(3)
Reviews
(2)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Caractéristiques microbiologiques et cliniques des patients hospitalisés pour suspicion d’infection à Middle East Respiratory Syndrome coronavirus (MERS-CoV) au cours de la période 2013–2016

C-reactive protein levels in the early stage of COVID-19

Features of anosmia in COVID-19

Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients

Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study

Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic

Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19

A clash of epidemics: Impact of the COVID-19 pandemic response on opioid overdose

Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine

Clinician perspectives on methadone service delivery and the use of telemedicine during the COVID-19 pandemic: A qualitative study

COVID-19-related treatment service disruptions among people with single- and polysubstance use concerns

Online digital recovery support services: An overview of the science and their potential to help individuals with substance use disorder during COVID-19 and beyond

Perspectives of opioid use disorder treatment providers during COVID-19: Adapting to flexibilities and sustaining reforms

Telehealth sustains patient engagement in OUD treatment during COVID-19

Focus on Middle East respiratory syndrome coronavirus (MERS-CoV)

Reimagining patient-centered care in opioid treatment programs: Lessons from the Bronx during COVID-19

Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis

Changes in methadone take-home dosing before and after COVID-19

The impact of COVID-19 on substance use disorder treatment in California: Service providers' perspectives

The provision of counseling to patients receiving medications for opioid use disorder: Telehealth innovations and challenges in the age of COVID-19

Impacts of COVID-19 on residential treatment programs for substance use disorder

Low-barrier buprenorphine during the COVID-19 pandemic: A rapid transition to on-demand telemedicine with wide-ranging effects

Rapid transitional response to the COVID-19 pandemic by opioid agonist treatment programs in Ukraine

Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade?

Using telehealth to improve buprenorphine access during and after COVID-19: A rapid response initiative in Rhode Island

Aktive Filter

Suchergebnisse filtern